Clincosm LogoSign in Get a demo

genital wart

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, Genital Wart, CIN Trial in Nanning (Zerun HPV-9, GARDASIL ®9)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • Zerun HPV-9
  • GARDASIL ®9
  • Nanning, Guangxi, China
    GuangXi Center for Diseases Control and Prevention
Oct 26, 2022

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

Completed
  • HPV Infections
  • +14 more
  • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  • Active Comparator: GARDASIL ®9
  • Guangxi, China
    Guangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

    Recruiting
    • HPV Infections
    • +6 more
    • 2-doses Group among 9-14 years
    • +2 more
    • Mianyang, Sichuan, China
      Center for Disease Control and Prevention
    Feb 23, 2022

    HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

    Recruiting
    • HPV Infections
    • +14 more
    • 9-valent HPV vaccine
    • Hangzhou, China
      Huakun Lv
    Feb 23, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

    Completed
    • Cervical Cancer
    • +13 more
    • 4-valent HPV Vaccine
    • +2 more
    • Yangchun, Guangdong, China
      Yangchun Center For Disease Prevention And Control
    Feb 23, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

    Recruiting
    • Cervical Cancer
    • +13 more
    • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
    • GARDASIL®
    • Rongan County, Guangxi Zhuang Autonomous Region, China
      Rongan County Center for Disease Control and Prevention
    Feb 20, 2022

    Cervical Cancer, Vulvar Cancer, Anus Cancer Trial in Solna (Information T1, Information T2, Information C)

    Enrolling by invitation
    • Cervical Cancer
    • +7 more
    • Information T1
    • +2 more
    • Solna, Stockholm, Sweden
      Karolinska Institutet, Medicinsk epidemiologi och biostatistik
    Jun 8, 2021

    Genital Wart and Sexuality in Adolescence

    Completed
    • Adolescent Development
    • +3 more
    • Clinical assessment
    • Ankara, Turkey
      Ankara City Hospital
    Mar 11, 2021

    Cervical Cancers, Vulvar Cancer, Vaginal Cancer Trial in Hanzhou (9-valent HPV Recombinant Vaccine, Placebo)

    Completed
    • Cervical Cancers
    • +14 more
    • 9-valent HPV Recombinant Vaccine
    • Placebo
    • Hanzhou, China
      Zhejiang Provincial Center for Disease Control and Prevention
    Jan 20, 2020

    Safety and Efficacy of Laser Therapy in Gynaecology

    Unknown status
    • Herpes Genitalis
    • +7 more
      • Ljubljana, Slovenia
        Juna
      Aug 28, 2019

      Genital Wart Trial (tuberculin, cryotherapy)

      Unknown status
      • Genital Wart
      • tuberculin
      • cryotherapy
      • (no location specified)
      May 15, 2017

      Genital Wart Trial in Wuhan (cyclophosphamide)

      Completed
      • Genital Wart
      • Wuhan, Hubei, China
        Tongji Hospital
      Nov 24, 2009